First surgeries are complete in the U.S. with Medacta’s cobalt-free SensiTiN Double Mobility Converter, following FDA clearance and positive EU market introduction in 2021.
Double Mobility devices are designed to address instability in primary and revision total hip replacement. To date, most of the Double Mobility Converters on the market are made of Cobalt-Chromium alloys, with several papers reporting corrosion of the taper connection.
The SensiTiN DM Converter is a cobalt-free, high-nitrogen-stainless steel modular DM device with an outer Titanium Nitride coating (SensiTiN), designed to improve corrosion resistance.
First surgeries are complete in the U.S. with Medacta's cobalt-free SensiTiN Double Mobility Converter, following FDA clearance and positive EU market introduction in 2021.
Double Mobility devices are designed to address instability in primary and revision total hip replacement. To date, most of the Double Mobility Converters on the market are...
First surgeries are complete in the U.S. with Medacta’s cobalt-free SensiTiN Double Mobility Converter, following FDA clearance and positive EU market introduction in 2021.
Double Mobility devices are designed to address instability in primary and revision total hip replacement. To date, most of the Double Mobility Converters on the market are made of Cobalt-Chromium alloys, with several papers reporting corrosion of the taper connection.
The SensiTiN DM Converter is a cobalt-free, high-nitrogen-stainless steel modular DM device with an outer Titanium Nitride coating (SensiTiN), designed to improve corrosion resistance.
Copy to clipboard 
